Gene therapy preparations manufacturing · California

Allogene Therapeutics

Newark, CA · ~62 workers · 4 years of OSHA Injury Tracking Application data.

B
Good Safety Record
1.8
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Allogene Therapeutics runs at 54% of its industry's injury rate - safer than the typical Gene therapy preparations manufacturing workplace, earning a grade B.

Allogene Therapeutics: 1.8 TCR = 54% of Gene therapy preparations manufacturing BLS 3.3 · 4y Form 300A (see methodology below)

Allogene Therapeutics safety composite

Allogene Therapeutics scores strongest on dart rate (safer than 83% of same-industry peers) and weakest on total case rate (tcr) (safer than 33%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

C

55/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
F 1.79 per 100 workers

Safer than 33% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Allogene Therapeutics held a steady TCR band

Allogene Therapeutics's TCR held near 0.0 from 0.0 in 2021 to 0.0 in 2024. Peak filing year was 2022 at 5.6 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).

2021=0.0 · 2022=5.6 · 2023=1.6 · 2024=0.0

OSHA ITA Form 300A scorecard

Establishment book 325414 · Newark, CA AT/BELOW-IND · SMALL

Grade B · TCR 1.8 · 54% of ind

  • DART 0.0 DART
  • RANK #15/29
  • PHOTO Elkhorn, NE Facility
  • BOOK 4y book
  • INJ 1 inj
  • SIZE ~62 FTE

Nearest TCR peer: Elkhorn, NE Facility (0.0 TCR gap)

Read with this employer → · Industry book → · California employers → · Look up another →

Allogene Therapeutics in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Allogene Therapeutics averages 1.8 TCR (54% of the Gene therapy preparations manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Allogene Therapeutics TCR series: 2021=0 · 2022=5.6 · 2023=1.6 · 2024=0 · BLS 3.3

Where Allogene Therapeutics falls in its industry

234 Gene therapy preparations manu establishments

Safer than 33% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #15 safest of 29 Gene therapy preparations manu employers in California.

Allogene Therapeutics (62 employees, TCR 1.8) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate Allogene Therapeutics
Allogene Therapeutics (62 employees, TCR 1.8) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Allogene Therapeutics has fewer employees than the Gene therapy preparations manufacturing median and a higher injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 1.6 0.0 1 0 0
2022 5.6 5.6 0 4 0
2021 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · CA · Newark

234 Gene therapy preparations manufacturing employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 92 employers in Newark, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Elkhorn, NE Facility 1.8 TCR
NAICS-TCR Thermo Fisher Scientific 1.8 TCR
NAICS-TCR Madison West 1.8 TCR
NAICS-TCR DeSoto, KS Facility 1.8 TCR
STATE-SIZE Zipper Farms, Inc. 62 FTE
STATE-SIZE Crain Marketing, Inc. 62 FTE
STATE-SIZE Maricopa Orchards, LLC 62 FTE
STATE-SIZE WESTLAND ORCHIDS 62 FTE
CITY-NEAR California Department of Transportation Facility 627 2,891 FTE
CITY-NEAR Lucid Motors HQ 2,632 FTE
CITY-NEAR Amazon Transportation Services : OAK5 2,181 FTE
CITY-NEAR Amazon.com Services LLC - OAK5 1,865 FTE
NAT-TCR Pegasus Industries & Packaging -Cane Run Road 1.8 TCR
NAT-TCR Environmental Holdings Group 1.8 TCR
NAT-TCR Hazelwood, MO 1.8 TCR
NAT-TCR Equipment Depot Texas, Inc. - Longview 1.8 TCR
NAT-SIZE HC White Mountain 62 FTE
NAT-SIZE Lake Assault Boats, LLC 62 FTE
NAT-SIZE 911 Emergency Call Center 62 FTE
NAT-SIZE Seneri Logistics, LLC 62 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022, 2021. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.